The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
Dems face uphill battle in challenge to Georgia Congressional map under new SCOTUS rules
Abdul El-Sayed peppered with questions on Hasan Piker link, fracture with Jewish Dems at Michigan convention
UN Told Merchant Ships Not to Arm Themselves Against Pirates as Piracy Escalates
NYC parolee accused of killing 2 in 48-hour robbery spree hauled in after manhunt, cops say
Video: Parent Trips Youth Football Player Who Was Headed for a Touchdown
Beer bandits swipe PBR truck hauling 50,000 cans in California, leaving brand pleading for help
Dem House hopeful’s delayed disclosure reveals mystery payments from Soros-linked groups
Trump touts access to 65 billion barrels of Venezuelan oil in deal he says will slash gas prices
Pennsylvania commissioner accuses Shapiro of ‘deceptive’ measles death framing as RFK Jr blasts Dem governor
MS NOW’s O’Donnell Fumes at Trump Sharing Old Military School Pic, Gets Every Aspect of His ‘Report’ Wrong During Tantrum
Tech Giant Details How Its AI Went Haywire
Canadian Nat’l Broadcaster Caves to Outrage, Will Refer to 9/11 as ‘Terrorist Attacks’ After Insane Internal Memo Leaked
Trump confirms Pentagon plans for 25th anniversary of 9/11 attacks, disputes report on Ground Zero absence
Pop star-turned-Dem candidate’s defense of graphic murder video resurfaces in key House race
Op-Ed: Family Formation Shouldn’t Be America’s Hardest Economic Choice
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
Dems face uphill battle in challenge to Georgia Congressional map under new SCOTUS rules
Abdul El-Sayed peppered with questions on Hasan Piker link, fracture with Jewish Dems at Michigan convention
UN Told Merchant Ships Not to Arm Themselves Against Pirates as Piracy Escalates
NYC parolee accused of killing 2 in 48-hour robbery spree hauled in after manhunt, cops say
Video: Parent Trips Youth Football Player Who Was Headed for a Touchdown
Beer bandits swipe PBR truck hauling 50,000 cans in California, leaving brand pleading for help
Dem House hopeful’s delayed disclosure reveals mystery payments from Soros-linked groups
Trump touts access to 65 billion barrels of Venezuelan oil in deal he says will slash gas prices
Pennsylvania commissioner accuses Shapiro of ‘deceptive’ measles death framing as RFK Jr blasts Dem governor
MS NOW’s O’Donnell Fumes at Trump Sharing Old Military School Pic, Gets Every Aspect of His ‘Report’ Wrong During Tantrum
Tech Giant Details How Its AI Went Haywire
Canadian Nat’l Broadcaster Caves to Outrage, Will Refer to 9/11 as ‘Terrorist Attacks’ After Insane Internal Memo Leaked
Trump confirms Pentagon plans for 25th anniversary of 9/11 attacks, disputes report on Ground Zero absence
Pop star-turned-Dem candidate’s defense of graphic murder video resurfaces in key House race
Op-Ed: Family Formation Shouldn’t Be America’s Hardest Economic Choice
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
